GAO Makes Appointments to PCORI Governing Board
WASHINGTON, DC (September 23, 2024) — Gene L. Dodaro, Comptroller General of the United States and head of the U.S. Government Accountability Office (GAO), today announced the reappointment of seven members and one new member to the Governing Board of the Patient-Centered Outcomes Research Institute (PCORI).
“The professional credentials and extensive knowledge of today’s appointees will bring strong leadership to the PCORI Governing Board,” Dodaro said. “Their invaluable experiences and diverse backgrounds will help drive the PCORI mission forward in maintaining clinical research that continues to be patient centered.”
Dodaro reappointed the following members to a second term through September 2030: Kara Ayers, Ph.D., Associate Professor in the Department of Pediatrics at the University of Cincinnati and Associate Director of the University of Cincinnati Center for Excellence in Developmental Disabilities; Kate Berry, Senior Vice President of Clinical Innovation with America’s Health Insurance Plans (AHIP); Jennifer (Jen) DeVoe (Vice Chairperson), M.D., MPhil, MCR, DPhil, FAAFP, John & Sherrie Saultz Professor and Chair of the Oregon Health & Science University Department of Family Medicine; Christopher Friese, Ph.D., RN, AOCN, FAAN, Director of the Center for Improving Patient and Population Health and Professor at the University of Michigan School of Nursing; Michael Herndon, D.O., Chief Medical Officer at Health Alliance for the Uninsured and former Chief Medical Officer for the Oklahoma Healthcare Authority (retired); James Schuster, M.D., MBA, Chief Medical Officer at the UPMC Insurance Services Division; and Christopher L. White, Esq., General Counsel and Chief Policy Officer of AdvaMed.
The newly appointed member will fulfill the statutory requirement to appoint at least one individual representing a federal health program or agency. Hilary Marston, M.D., MPH, Chief Medical Officer of the Food and Drug Administration (FDA) is appointed for a six-year term through September 2030 and may be reappointed for one subsequent six-year term. A brief biography follows:
As FDA’s Chief Medical Officer, Dr. Marston serves as the primary clinical advisor to the Commissioner and oversees a range of issues important to the patient community. Dr. Marston leads programs and cross-cutting initiatives that support making effective, safe, and innovative medical products available to the American people, including combination products, pediatric therapeutics and orphan products for rare diseases. Her portfolio also includes planning for and responding to public health emergencies, including medical product supply chain coordination, and cross-cutting clinical trial oversight-related issues, including evidence generation and informed consent. In close collaboration with FDA’s medical product centers, she supports patient engagement activities to foster awareness and collaboration with patients, their advocates, stakeholders, and the FDA. Dr. Marston previously served on the White House COVID-19 Response Team and the National Security Council. Prior to these roles, she was Policy Advisor for Pandemic Preparedness at the National Institute of Allergy and Infectious Diseases. Dr. Marston trained in Internal Medicine and Global Health Equity at Brigham & Women's Hospital. She completed her M.P.H. at the Harvard T.H. Chan School of Public Health.
For more information, contact Ray Sendejas on GAO's Health Care team at (202) 512-7113, or Sarah Kaczmarek in GAO's Office of Public Affairs at (202) 512-4800, or visit the GAO Health Care Advisory Committees web page at www.gao.gov/about/hcac.
#####
The Government Accountability Office, known as the investigative arm of Congress, is an independent, nonpartisan agency that exists to support Congress in meeting its constitutional responsibilities. GAO also works to improve the performance of the federal government and ensure its accountability to the American people. The agency examines the use of public funds; evaluates federal programs and policies; and provides analyses, recommendations, and other assistance to help Congress make informed oversight, policy, and funding decisions. GAO provides Congress with timely information that is objective, fact-based, nonideological, fair, and balanced. GAO’s commitment to good government is reflected in its core values of accountability, integrity, and reliability.